VRC 611: A Phase I Safety and Pharmacokinetics Study to Evaluate a Human Monoclonal Antibody (mAb) VRC-HIVMAB0102-00-AB (CAP256V2S) Administered Via Subcutaneous and Intravenous Injection in Healthy Adults

Condition:   HIV Intervention:   Biological: VRC-HIVMAB0102-00-AB Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials